Hepatoblastoma
Hepatoblastoma is a rare type of liver cancer that primarily affects young children, often presenting with abdominal swelling and pain.
Patritumab Deruxtecan for Pediatric Solid Tumors
We are studying a new treatment for children with relapsed or refractory solid tumors to see if it is safe and effective. This trial aims to understand how well it works compared to existing options.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Rhabdomyosarcoma
Rhabdomyosarcoma is a rare cancer that develops in soft tissues, commonly affecting children and often presenting as a lump or swelling in the affected area.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have advanced or metastatic solid tumors like Rhabdomyosarcoma or Hepatoblastoma?
- Have you had major surgery in the past 3 months?
- Do you have an active infection that requires treatment?
- Have you had a solid organ transplant?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Mk-1022
Patritumab Deruxtecan
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Pediatric Oncology
Ledeberg, Belgium
Fakultni Nemocnice Brno
Klinika dětské onkologie
Brno, Czechia
Fakultni Nemocnice V Motole
Klinika dětské hematologie a onkologie
Stodůlky, Czechia
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.